Marengo CIMS Hospital continues to redefine the future of cardiac care by offering advanced transcatheter valve replacement therapies that provide life-saving solutions without the need for open-heart surgery. These minimally invasive procedures are especially beneficial for high-risk patients, elderly individuals, and those with multiple co-morbidities, ensuring faster recovery, reduced hospital stay, and improved quality of life.
A significant milestone in this journey is Gujarat’s First Transcatheter Tricuspid Valve Replacement (TTVR) performed at Marengo CIMS Hospital. Traditionally, tricuspid valve disease was often under-treated due to the high surgical risk involved. TTVR has emerged as a revolutionary, non-surgical alternative that allows precise replacement of the damaged tricuspid valve through a catheter-based approach. This breakthrough offers renewed hope to patients suffering from severe tricuspid regurgitation, helping alleviate symptoms such as breathlessness, fatigue, and fluid retention, while restoring functional independence.
Alongside TTVR, Marengo CIMS Hospital has also demonstrated extensive expertise in Transcatheter Aortic Valve Implantation (TAVI) and Transcatheter Mitral Valve Replacement (TMVR). TAVI has become a well-established option for patients with aortic valve stenosis who are unsuitable for conventional surgery, while TMVR addresses complex mitral valve diseases with remarkable precision and safety. Together, these procedures represent a comprehensive spectrum of structural heart interventions tailored to individual patient needs.
With 76 successful transcatheter valve procedures, including 65 TAVI, 10 TMVR, and 1 landmark TTVR, Marengo CIMS Hospital stands at the forefront of innovation in cardiac care. Supported by a highly skilled multidisciplinary heart team, advanced imaging, and cutting-edge technology, the hospital remains committed to delivering compassionate, world-class, and patient-focused heart care—truly embodying the philosophy of Human Care by Practice.